Vascular endothelial growth factor upregulation in human central retinal vein occlusion

Ophthalmology

Volumn 105, Issue 3, 1998, Pages 412-416

  Pe'er, Jacob ^a   Folberg, Robert ^b   Itin, Ahuva ^c   Gnessin, Hadassah ^a   Hemo, Itzhak ^a   Keshet, Eli ^c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF IOWA   (United States)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ARTICLE; CENTRAL RETINA VEIN OCCLUSION; HUMAN; MESSENGER RNA SYNTHESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION;

EID: 0031940281     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)93020-2     Document Type: Article

References (30)

1. Sanborn GE, Magargal LE, Jaeger EA. Venous occlusive disease of the retina. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. Philadelphia: Lippincott-Raven Publishers, 1986; v. 3, chap. 15.
2. Green WR. Retina. In: Spencer WH, ed. Ophthalmic Pathology: An Atlas and Textbook, 4th ed. Philadelphia: Saunders, 1996, v. 2. chap. 9.
3. Hayreh SS, Rojas P, Podhajsky P, et al. Ocular neovascularization with retinal vascular occlusion - III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983;90:488-506.
4. Magargal LE, Brown GC, Augsburger JJ, et al. Neovascular glaucoma following central retinal vein obstruction. Ophthalmology 1981;88:1095-101.
5. Sinclair SH, Gragoudas ES. Prognosis of rubeosis iridis following central retinal vein occlusion. Br J Ophthalmol 1979;63:735-43.
6. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948;65:137-80.
7. Ashton N. Retinal vascularization in health and disease. Proctor Award Lecture at the Association for Research: Ophthalmology. Am J Ophthalmol 1957;44(4 Pt II):7-17.
8. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
9. Pe'er J, Shweiki D, Itin A, et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995;72:638-45.
10. Pe'er J, Folberg R, Itin A, et al. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 1996;80:241-5.
11. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445-50.
12. Malecaze F, Clamens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994; 112:1476-82.
13. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7.
14. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 1996;114:66-71.
15. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 1995;92:10457-61.
16. Shima DT, Gougos A, Miller JW, et al. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. Invest Ophthalmol Vis Sci 1996;37:1334-40.
17. Pierce EA, Avery RL, Foley ED, et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 1995;92:905-9.
18. Wise GN. Retinal neovascularization. Trans Am Ophthalmol Soc 1956;52:729-826.
19. Stefansson E, Landers MB III, Wolbarsht ML, Klintworth GK. Neovascularization of the iris: an experimental model in cats. Invest Ophthalmol Vis Sci 1984;25:361-4.
20. Little HL, Rosenthal AR, Dellaporta A, Jacobson DR. The effect of pan-retinal photo-coagulation on rubeosis iridis. Am J Ophthalmol 1976;81:804-9.
21. Hayreh SS, Klugman MR, Podhajsky P, et al. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study. Graefes Arch Clin Exp Ophthalmol 1990;228:281-96.
22. Murdoch IE, Rosen PH, Shilling JS. Neovascular response in ischemic central retinal vein occlusion after panretinal photocoagulation. Br J Ophthalmol 1991;75:459-61.
23. Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024-8.
24. King GL, Goodman AD, Buzney S, et al. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985;75:1028-36.
25. Grant M, Russell B, Fitzgerald C, Merimee TJ. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization. Diabetes 1986;35:416-20.
26. Sivalingam A, Kenney J, Brown GC, et al. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990;108: 869-72.
27. Fredj-Reygrobellet D, Baudouin C, Negre F, et al. Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy. Ophthalmic Res 1991;23:154-61.
28. Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 1992;36:373-84.
29. Glaser BM. Extracellular modulating factors and the control of intraocular neovascularization. An overview. Arch Ophthalmol 1988;106:603-7.
30. Laatikainen L, Kohner EM. Fluorescein angiography and its prognostic significance in central retinal vein occlusion. Br J Ophthalmol 1976;60:411-8.